Latest Vaccination Stories
The vaccine based on Cytos' Virus-Like Particle technology may open the door to accelerated production of influenza vaccines in SingaporeSingapore and Schlieren (Zurich), Switzerland, May 17, 2013 - (ACN Newswire) - Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos'...
HARRISBURG, Pa., May 16, 2013 /PRNewswire/ -- The Pennsylvania Pharmacists Association announced today that numerous physicians throughout the Commonwealth are urging state legislators to support House Bill 776, which would expand pharmacist provided immunizations to patients over the age of seven. In letters sent to the House Professional Licensure Committee earlier this month, the physicians requested that members support the measure and vote it out of committee in the very near...
According to the CDC, to ensure the quality of vaccinations administered to patients, it is extremely important for vaccine manufacturers, distributors and healthcare facilities to follow proper storage and handling protocols. Coral Gables, FL (PRWEB) May 15, 2013 TransactRx the nation’s leading Medicare Part D Vaccine Physician Billing Service announced today that it has released Part Two – Vaccine Handling and Storage of its five-part educational series titled “Running a...
Design Enables More Rapid Response to Potential Pandemics LA JOLLA, Calif. and ROCKVILLE, Md., May 15, 2013 /PRNewswire/ -- A team of international researchers from the J. Craig Venter Institute (JCVI), Synthetic Genomics Inc. (SGI), Novartis Vaccines and Diagnostics, the Biomedical Advanced Research and Development Authority (BARDA, US Department of Health and Human Services), and Institut fur Virologie, Phillips Universitat, has published a study detailing new methods to rapidly generate...
Interim Phase II Data and Follow-Up Analysis of Phase I Data Presented at Annual Meeting of the American Society of Gene and Cell Therapy DALLAS, May 15, 2013 /PRNewswire/ -- Today Gradalis, Inc. announced that FANG(TM), the company's tumor-based personalized cancer vaccine, elicits an immune response and delays time to recurrence in advanced stage ovarian cancer patients by more than one year compared to patients who received standard of care. Interim analysis of the Phase II...
LOS ANGELES, May 15, 2013 /PRNewswire/ -- Kite Pharma Inc. (Kite), a clinical stage biotechnology company focused on developing innovative targeted immunotherapies for cancer, today announced that it has closed a $20 million private placement of shares of its Series A Preferred Stock. In addition to the $20 million in new funds, Kite converted $15 million in outstanding promissory notes into shares of Series A Preferred Stock. Joined by a new investor, Alta Partners, all existing...
BEIJING, May 15, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, has appointed China-based Ernst & Young Hua Ming LLP as its registered independent public accounting firm effective from May 14, 2013 to replace Ernst & Young LLP Canada. On May 14, 2013, Ernst & Young LLP Canada notified the Company that it would not stand for re-election as the Company's registered independent public accounting firm....
Polyvalent Vaccine Design Stimulates Significant Antibody and T-Cell Responses with 100% Survival Against Multiple Families of Most Lethal Virus Known to Man BLUE BELL, Pa., May 14, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that in a preclinical study of Inovio's SynCon(®) DNA vaccine against Ebola and Marburg filoviruses, labeled "Category A" bioterrorism agents by the U.S. government, the vaccine induced strong and broad immune responses and...
BEIJING, May 14, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that management is scheduled to present at the UBS Global Healthcare Conference in New York City. The Sinovac management team inclusive of Nan Wang, Vice President, and Helen Yang, Director, Investor Relations and International Business Development, will present at 10:00 am ET on Monday, May 20, 2013. About Sinovac Sinovac...
NES ZIONA, Israel, May 13, 2013 /PRNewswire/ -- NanoPass Technologies Ltd. ("NanoPass"), a pioneer in intradermal (into-the-skin or ID) vaccine delivery solutions, is collaborating with the US Center of Disease Control and prevention (CDC) in conducting a large phase 3 trial of polio vaccine in infants in South East Asia. This collaboration is a part of NanoPass's long-term commitment to improve Global Health by providing access to its vaccine delivery devices....
Latest Vaccination Reference Libraries
The Cowpox virus causes a skin disease known as cowpox. It is related to the vaccinia virus and gained its name because it spread by dairymaids touching the udders of infected cows. It manifests as red blisters. It is similar to smallpox although much milder and was actually the basis of the first smallpox vaccine. A person who recovers from cowpox is immune to smallpox. In 1980 the World Health Organization announced that smallpox was the first disease to be eradicated world wide by a...
